Evidence map›Paper›PMID 21852270›Full record

ArticleMutagenesis2012

Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs.

Stuart Creton, Marilyn J Aardema, Paul L Carmichael, James S Harvey, Francis L Martin, Robert F Newbold, Michael R O'Donovan, Kamala Pant, Albrecht Poth, Ayako Sakai and 6 more

Abstract read
In one paragraph

Article in Mutagenesis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Computational toxicology (Amsterdam, Netherlands) · 2021
    Article
  7. The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Roles ofJournal of genetics · 2018
    Article
  13. Article
  14. Moving forward in carcinogenicity assessment: Report of an EURL ECVAM/ESTIV workshop.Toxicology in vitro : an international journal published in association with BIBRA · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Stuart CretonNational Centre for the Replacement, Refinement and Reduction of Animals in Research, Gibbs Building, 215 Euston Road, London NW1 2BE, UK. stuart.creton@nc3rs.org.uk
Marilyn J Aardema
Paul L Carmichael
James S Harvey
Francis L Martin
Robert F Newbold
Michael R O'Donovan
Kamala Pant
Albrecht Poth
Ayako Sakai
Kiyoshi Sasaki
Andrew D Scott
Leonard M Schechtman
Rhine R Shen
Noriho Tanaka
Hemad Yasaei

Funding

National Centre for the Replacement, Refinement and Reduction of Animals in Research G0800697/1
6 · The paper itself

Abstract

Cell transformation assays (CTAs) have long been proposed as in vitro methods for the identification of potential chemical carcinogens. Despite showing good correlation with rodent bioassay data, concerns over the subjective nature of using morphological criteria for identifying transformed cells and a lack of understanding of the mechanistic basis of the assays has limited their acceptance for regulatory purposes. However, recent drivers to find alternative carcinogenicity assessment methodologies, such as the Seventh Amendment to the EU Cosmetics Directive, have fuelled renewed interest in CTAs. Research is currently ongoing to improve the objectivity of the assays, reveal the underlying molecular changes leading to transformation and explore the use of novel cell types. The UK NC3Rs held an international workshop in November 2010 to review the current state of the art in this field and provide directions for future research. This paper outlines the key points highlighted at this meeting.

Indexed as

AnimalsBiomarkersCarcinogenicity TestsCarcinogensCell LineCell Transformation, NeoplasticCongresses as TopicCosmeticsHumansValidation Studies as TopicBiomarkersCarcinogensCosmetics

Identifiers

PMID21852270
PMCPMC3241940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.